Comparative Evaluation of the Safety and the Efficacy of 2 Antimalarials Depending on HIV Status
Status:
Terminated
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of
sulfadoxine-pyrimethamine (SP) versus artemether-lumefantrine (Coartem) when administered to
HIV+ and HIV- patients with uncomplicated P. falciparum malaria. Patients will be randomised
to one of the 2 treatment and followed up (until day 14 actively) for 45 days.
Phase:
N/A
Details
Lead Sponsor:
Institute of Tropical Medicine, Belgium
Treatments:
Artemether Artemether-lumefantrine combination Artemether, Lumefantrine Drug Combination Artemisinins Fanasil, pyrimethamine drug combination Lumefantrine Pyrimethamine Sulfadoxine